Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30080785 | 1.00 | RXFP1 (0.46) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL17899360 | 0.92 | ALDH1A1 (0.54) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL29527488 | 0.92 | ALDH1A1 (0.54) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL17174142 | 0.90 | RAB9A (0.42) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL21849527 | 0.90 | ALDH1A1 (0.58) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL17174150 | 0.88 | AGTR1 (0.44) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL17174161 | 0.85 | AGTR1 (0.49) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL11973463 | 0.85 | LMNA (0.55) | MEN1KMT2ARAB9ASMN1; SMN2NPC1 | |
| SCHEMBL17174140 | 0.84 | AGTR1 (0.47) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 | |
| SCHEMBL10041709 | 0.82 | CYP1A1 (0.51) | RXFP1MEN1KMT2ARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2896621-B1 | NOVEL COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-12 | — | — | US | disclosed |
| US-9871206-B2 | Compound, organic electroluminescence device material, organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
| US-20160197289-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | CBX8, MLX, HAX1 | RXFP1 76/4885MEN1 1424/4885KMT2A 1095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.